Scientific publications

Annals of Hematology, 2026

Mendelian randomization analysis of immune cell subsets and inflammatory cytokines in aplastic anaemia

Hu K., Cheng Y., Xiao G. et al.

Journal of Human Genetics, 2026

Meta-analyses of genome-wide association studies identify novel loci influencing Japanese white matter hyperintensities

Asanomi Y., Mitsumori R., Yamakawa A. et al.

Molecular Therapy Advances, 2026

The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humans

Ryberg E., Bergström F., Sten S. et al.

Medicine, 2026

Association of programmed cell death with atrial fibrillation risk: A multi-omics Mendelian randomization study

Liu K., Han X., Chen Y.

European Heart Journal, 2026

Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study

Kakizaki R., Biccirè F., Losdat S. et al.

Microorganisms, 2026

Immune Dysregulation and Cytokine Profiling in Acute Mycoplasma pneumoniae Pneumonia

Wen Y., Zhai Y., Sang S. et al.

Biomedicine & Pharmacotherapy, 2026

Integrated transcriptomic and proteomic profiling identifies an interferon-dependent inflammatory endotype in sepsis

Fratea A., Riza A., Dumitrescu F. et al.

Clinical Pharmacology in Drug Development, 2026

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies

Vendel A., Benichou O., Chang C. et al.

Molecular Neurodegeneration Advances, 2026

Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12

Farias Quipildor G., Belfiore R., Althobaiti K. et al.

Journal of Ethnopharmacology, 2026

OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study

Chen G., Zhou S., Chen Y. et al.

Journal of Cachexia, Sarcopenia and Muscle, 2026

Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma‐Based Diagnostic Models of Sarcopenia

Xu D., Jin H., Yang J. et al.

Neurology Neuroimmunology & Neuroinflammation, 2026

Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis

Chitnis T., Singhal T., Zurawski J. et al.

Frontiers in Immunology, 2026

Circulating fibroblasts and neutrophils co-expressing CDH11+ and chemokine receptors in rheumatoid and psoriatic arthritis: a shared mechanism of ‘arthritis spreading’?

Kyriakidi M., Vetsika E., Fragoulis G. et al.

Nature Medicine, 2026

Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial

Donovan J., Duc Bang N., Dong H. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2026

Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis

Eindor‐Abarbanel A., Moss‐ Ophir N., Agajany N. et al.

Blood Neoplasia, 2026

Proteome-wide Mendelian Randomisation Identifies Protein Associations and Therapeutic Targets for B-cell Malignancy

Went M., Mills C., Sud A. et al.

Annals of the Rheumatic Diseases, 2026

Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach

Cross H., Peng J., McDonnell T. et al.

Cytotherapy, 2026

Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL

Lauener M., Normand M., Ngo T. et al.

Metabolism, 2026

Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: A prospective cohort study

Huang Y., Zhang Y., Zhang Y. et al.

mBio, 2026

Lineage-matched Oropouche virus mRNA-LNP vaccines confer complete, cross-protective immunity in mice

Yamada Y., Cha I., Kang S. et al.